Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer

Clinical Breast Cancer
D E ReeceG L Phillips

Abstract

The anti-idiotype monoclonal antibody breast cancer vaccine 11D10 (TriAb) was administered before and after autologous stem cell transplantation (ASCT) in 45 patients with metastatic breast cancer whose disease was responsive to conventional chemotherapy. Evidence of a positive anti-anti-idiotype antibody (Ab3) humoral response was noted at a median of 1.76 months post-ASCT (range, before ASCT-6 months) with this strategy. Maximal Ab3 levels and idiotype-specific T-cell proliferative responses were observed at a median of 3 and 4 months, respectively, after ASCT. The achievement of rapid immune responses after ASCT, during a known period of decreased immunoresponsiveness, opens the possibility of an additional antitumor effect at a time when the tumor burden is relatively small. Moreover, in this interim analysis, patients with the most vigorous humoral and cellular immune responses had a significant improvement in progression-free survival. Further follow-up and evaluation of this approach is warranted.

References

Jul 1, 1995·The Journal of Clinical Investigation·K A FoonM Bhattacharya-Chatterjee
Feb 12, 1998·The Journal of Clinical Investigation·V KaranikasI F McKenzie
Apr 29, 2000·Current Opinion in Hematology·T L Warren, G J Weiner
Jul 6, 2000·Cancer Immunology, Immunotherapy : CII·M Bhattachary-ChatterjeeK A Foon

❮ Previous
Next ❯

Citations

Jun 23, 2004·Critical Reviews in Oncology/hematology·A RossiC Gridelli
Jun 5, 2004·Expert Review of Vaccines·Leona A Holmberg, Brenda Sandmaier
May 24, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Florent CachinRodney J Hicks
May 29, 2007·Oncogene·A López-Díaz de CerioM Bendandi
Apr 14, 2004·Memory & Cognition·Jason D Zevin, Mark S Seidenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.